Author(s):
Srinivasa B, M. L. Ramyakrishna, Madhav P, Sudharshan V
Email(s):
snsrinivasan93@gmail.com
DOI:
10.52711/0974-360X.2024.00718
Address:
Srinivasa B1*, M. L. Ramyakrishna2, Madhav P3, Sudharshan V4
1Assistant Professor, Dept. of Pharmacology, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
2Assistant Professor, Dept. of Physiotherapy, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
3Associate Professor, Dept. of Pharmacology, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
4Under Graduate (MBBS 2nd Phase), Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 10,
Year - 2024
ABSTRACT:
Drug induced adverse drug reactions and events are quite common nowadays. Among those stevens-johnson syndrome (SJS) is one of the rare Severe Cutaneous Adverse Drug Reaction (SCAR) which is characterized by typical peeling of skin, mucous membrane and epidermal detachment. The incidence of Griseofulvin induced Stevens-Johnson syndrome is less than 1%. Here the patient initially went to local doctor for complaints suggesting fungal dermatitis like diffuse itching following which she was started on Tab Griseofulvin 500mg BD for 5 days. The next day she came to district govt. hospital with complaints of typical peeled of lesions and pain over face, arms, trunk and peritoneal area for which topical steroid and oral corticosteroid was advised for 2 weeks with tapered doses in between after stopping Tab Griseofulvin was advised by the treating doctor. Later Histopathological examination of the skin sample was performed. which revealed the findings of SJS. The causal relationship of tab griseofulvin with SJS as per ALDEN Algorithm in one of the standard Euro SCAR study was found to be certain. The causality assessment score for this event SJS was found to be 7 as per naranjo’s ADR probability scale, henceforth the causal relationship with ADR is found to be certain . Treating physicians especially dermatologists must be more aware and vigilant before prescribing and advising Griseofulvin for any fungal diseases by doing regular follow-up of patients if advised and assessment of early diagnosis of these similar reactions could benefit the society by preventing the occurrences of SJS in future.
Cite this article:
Srinivasa B, M. L. Ramyakrishna, Madhav P, Sudharshan V. Griseofulvin Induced Stevens Johnson Syndrome (SJS). A Rare Case Report from District Headquarters Hospital, Chittoor, AP.. Research Journal of Pharmacy and Technology. 2024; 17(10):4663-6. doi: 10.52711/0974-360X.2024.00718
Cite(Electronic):
Srinivasa B, M. L. Ramyakrishna, Madhav P, Sudharshan V. Griseofulvin Induced Stevens Johnson Syndrome (SJS). A Rare Case Report from District Headquarters Hospital, Chittoor, AP.. Research Journal of Pharmacy and Technology. 2024; 17(10):4663-6. doi: 10.52711/0974-360X.2024.00718 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-10-3
REFERENCES:
1. Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Clin Dermatol. 2020; 38(6): 607-612. doi: 10.1016/j.clindermatol.2020.06.016. Epub 2020 Jun 30. PMID: 33341195.
2. Bellón T. Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances. Drug Saf. 2019; 42(8): 973-992. doi: 10.1007/s40264-019-00825-2. PMID: 31020549.
3. Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017; Oct 28; 390(10106): 1996-2011. doi: 10.1016/S0140-6736(16)30378-6. Epub 2017 May 2. Erratum in: Lancet. 2017 Oct 28;390(10106):1948. PMID: 28476287.
4. Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc. 2010; 85(2): 131-8. doi: 10.4065/mcp.2009.0379. PMID: 20118388; PMCID: PMC2813820.
5. Cheriyan S. Patterson R. Greenberger PA. Grammer LC. Latall J. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc. 1995; 16(4): 151–155. DOI: 10.2500/108854195778666793
6. Yakaiah Vangoori, Naga Vishnu Kandra, Praveen Kumar Uppala, U. Upendrarao, S.V. Saibaba, Murali Krishna Balijepalli, Butti Lavanya, SK. M. Shabana. Case Reports of Stevens Johnson Syndrome (SJS) Induced by Chemically Unrelated Drugs. Research Journal of Pharmacy and Technology. 2023; 16(5): 2415-8.
7. Das AR, Saikeerthana PC, Raj K, Anila KN. Carbamazepine induced toxic epidermal necrolysis – A rare case report. International Journal of Pharmaceutical Sciences Review and Research. 2016; 40 (2): 18-19.
8. Remya Antony, Ashly Fernandez, Sandhya Lekshmi, Sreedevan Velayudhan, Sruthy Jose, Meenu Vijayan. Case report on Fluconazole Induced stevens - Johnson Syndrome. Research J. Pharm. and Tech. 2019; 12(8): 3735-3738.
9. Ofoma UR and Chapnick EK. Fluconazole induced toxic epidermal necrolysis: a case report. Cases Journal. 2009; 2(1): 9071.
10. Sassolas B, Haddad C, Mockenhaupt M et al. ALDEN, an algorithm for assessment of drug causality in Stevens–Johnson syndrome and toxic epidermal necrolysis: comparison with case–control analysis. Clinical Pharmacology and Therapeutics. 2010; 88(1): 60-8.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; Aug; 30(2):239-45. doi: 10.1038/clpt.1981.154. PMID: 7249508.
12. Madaiah A. Gowda HN. Fatal phenytoin induced Stevens – Johnson syndrome in an elderly person with metastatic lung carcinoma. Natl J Physiol Pharm Pharmocol. 2016; 6: 175–177. DOI:10.5455/njppp.2016.6.25122015109.